Whitebox Advisors’s Terns Pharmaceuticals TERN Stock Holding History

Whitebox Advisors’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,000,001	Closed	-$52.7M	–	686
2026 Q1	$52.7M	Buy	+1,000,001	New	+$41.1M	0.64%	31

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Whitebox Advisors's TERN Position: Q2 2026 in Review

Whitebox Advisors sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 1,000,001 shares — an estimated $52.7M sold.

Whitebox Advisors first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $52.7M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Whitebox Advisors reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Whitebox Advisors sold 1,000,001 Terns Pharmaceuticals shares in Q2 2026, an estimated $52.7M.
Whitebox Advisors first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Whitebox Advisors's Terns Pharmaceuticals position peaked at $52.7M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Whitebox Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.